Patricia Miro
Family · White Plains, NYNPI 1821024407
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.9% of the total across 210 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $7,470, 2.9 times the $2,616 reported in 2021. Among family clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 210 payments — averaging $126.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- AstraZeneca$3K
- Boehringer Ingelheim$2K
- Teva Pharmaceuticals USA, Inc.$2K
- Novo Nordisk$2K
- E.r. Squibb & Sons, L.L.C.$1K
- plus $12K from 28 others
What the payments were for
- Consulting fees$8003%
- Travel & lodging$340%
- Food & beverage$25,70597%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 47 | $5,808 |
| AstraZeneca | 21 | $2,563 |
| Boehringer Ingelheim | 16 | $1,977 |
| Teva Pharmaceuticals USA, Inc. | 15 | $1,813 |
| Novo Nordisk | 13 | $1,539 |
| E.r. Squibb & Sons, L.L.C. | 9 | $1,122 |
| Biohaven Pharmaceuticals, Inc. | 4 | $1,084 |
| GSK | 8 | $963 |
| Lilly USA, LLC | 8 | $928 |
| Axsome Therapeutics, Inc. | 7 | $872 |
| Amgen | 7 | $865 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $768 |
| Bayer | 5 | $647 |
| Grifols USA, LLC | 6 | $635 |
| Otsuka America Pharmaceutical, Inc. | 5 | $622 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $533 |
| Johnson & Johnson | 4 | $523 |
| Abbott | 3 | $385 |
| Esperion Therapeutics, Inc. | 3 | $375 |
| Ipsen Biopharmaceuticals, Inc | 2 | $300 |
| Gilead | 2 | $257 |
| Phathom Pharmaceuticals, Inc. | 2 | $256 |
| Eisai Inc. | 2 | $249 |
| Sequel Med Tech, LLC | 1 | $157 |
| Averitas Pharma Inc. | 1 | $154 |
| Urovant Sciences Inc | 1 | $149 |
| Luye Pharma (USA) Ltd. | 1 | $130 |
| Sumitomo Pharma America, Inc. | 1 | $125 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $125 |
| Scpharmaceuticals Inc. | 1 | $125 |
| Pfizer | 1 | $125 |
| Seagen Inc. | 1 | $125 |
| Idorsia Pharmaceuticals US Inc | 1 | $123 |
| Intra-sana Laboratories | 1 | $119 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$26,540 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.
Other family in White Plains
- Martha FerraraWhite Plains$45K
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
- Cathrine CurtinBronxville$155K
- Mary Sullivan-WhalenNew York$137K
- Sarah AljahmiRockville Centre$87K
- John de OcaStaten Island$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.